Approval · Notice of Compliance 6913 · 1997
TRESADERM DERMATOLOGIC SOLUTION: Notice of Compliance 6913
Issued December 3, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6913
- Date
- December 3, 1997
- Company
- Merial Canada Inc.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Anti-inflammatory
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRESADERM DERMATOLOGIC SOLUTION | 00270512 | Cancelled Post Market |
Medicinal ingredients
- THIABENDAZOLE 40 MG per ML
- DEXAMETHASONE 1 MG per ML
- NEOMYCIN SULFATE 3.2 MG per ML